Buphenyl

Name: Buphenyl

Patient information

BUPHENYL®
(sodium phenylbutyrate) Tablets

BUPHENYL®
(sodium phenylbutyrate) Powder

What is the most important information I should know about BUPHENYL?

BUPHENYL is prescribed along with changes in diet for long-term treatment of urea cycle disorders. BUPHENYL can only be obtained with a prescription from your doctor.

BUPHENYL must be taken exactly as the doctor prescribes; do not increase or decrease the dose of this medication without the doctor's approval.

What are urea cycle disorders ?

Urea cycle disorders include a group of diseases, each having a specific liver enzyme deficiency. Because they are inherited, other family members may be affected. These disorders vary in severity and may be first detected at various ages, from newborn infants to adults. They lead to increased amounts of ammonia in the blood, which may cause disturbed brain function and severe brain damage. Typical signs of the disease are decreased mental awareness, vomiting, combativeness, slurred speech, unstable gait, and unconsciousness. The diagnosis of urea cycle disorders requires special laboratory tests. These typical signs of the disease may recur after the diagnosis is made if the condition is not under control. If they do, the doctor should be notified immediately because this is a medical emergency. An infection can cause the condition to go out of control. Therefore, if a fever develops, the doctor should be seen immediately.

A patient or carrier of these disorders should wear a Medic Alert tag stating the diagnosis. In the event that the patient has a sudden, rapid accumulation of ammonia in the blood, and, therefore, in the brain, leading to unconsciousness, the doctor will be alerted to treat the disease properly.

Periodically, depending upon the severity of a particular patient's urea cycle disorder, it will be necessary to perform blood tests. These include plasma ammonia, plasma amino acid levels, and other more routine blood tests to evaluate nutritional status.

What is BUPHENYL?

BUPHENYL is a drug that helps to prevent ammonia from accumulating in the blood. BUPHENYL aids the body in eliminating substances that produce ammonia. However, despite drug treatment, blood ammonia levels may become elevated periodically and there may be episodes of altered brain function in association with these ammonia elevations. Patients who have disease onset as newborns have a high incidence of mental retardation. Medical attention should be obtained as soon as signs appear (see above under “What are urea cycle disorders?”). BUPHENYL may be used as life-long therapy or as a temporary measure until liver transplantation is performed.

What diet should I or my child follow?

In addition to taking BUPHENYL, it is equally important that a prescribed diet be followed. Because there is great variability in the severity of urea cycle disorders, each patient's diet should be custom designed by a physician and a nutritionist. Because the diet is so important, it is recommended that the prescribed diet be discussed with a nutritionist who is familiar with urea cycle disorders.

Who should not take BUPHENYL?

BUPHENYL is prescribed only for patients with urea cycle disorders. It is not to be used for any other reason. Keep the medication in a safe place where children cannot reach it.

What other medical conditions may also be present that could increase the risk of taking BUPHENYL?

Heart failure or decreased kidney function may lead to retention of the sodium content of BUPHENYL with potentially serious consequences such as worsening heart failure, high blood pressure, and swelling. If these medical conditions are present, the doctor will determine if your child should take BUPHENYL.

How should I or my child take BUPHENYL?

The dose of BUPHENYL prescribed for adults and children is based upon the patient's weight or size. It is very important that the full amount prescribed for any 24-hour period be taken. If a dose is missed it should be administered as soon as possible that same day. The total daily dose should be administered in equally divided amounts with meals.

What medications should I or my child avoid or be cautious of taking while on BUPHENYL?

Patients with urea cycle disorders usually should not take Depakene (valproic acid), a drug sometimes prescribed for seizure disorders, or Haldol (haloperidol), a drug used to treat certain types of psychiatric or neurologic disorders. Both of these drugs have been reported to increase blood ammonia levels. Steroids may break down body protein, thereby increasing blood ammonia levels. The doctor should be consulted before administering medications containing steroids.

What medications may affect the way the body breaks down the drug?

Probenecid, a medication used to treat gout, may affect the way the kidneys excrete BUPHENYL (consult the doctor for details).

What are the most common side effects of BUPHENYL?

The most common side effect reported in premenopausal women taking BUPHENYL was absent or irregular menstrual periods. Decreased appetite was reported in 4% of all people treated. Body odor and bad taste were each reported in 3% of all patients treated.

A breakdown product of BUPHENYL has been associated mainly with sleepiness and light-headedness. Because these symptoms may also be due to the urea cycle going out of control, a doctor should see the patient immediately if these symptoms occur, so the cause can be determined. Blood tests should be performed periodically for adverse effects and for levels of medication and its breakdown products.

How should BUPHENYL be stored?

BUPHENYL should be stored in a tightly closed bottle at room temperature.

This leaflet provides a brief summary of the information available on BUPHENYL. The information here is incomplete and is not designed to take the place of your doctor's instructions. For more complete information, consult your physician, or contact Horizon Therapeutics, Inc. at 1-855-UCD-SUPT (1-855-823- 7878).

Buphenyl Precautions

Serious side effects have been reported with Buphenyl including neurotoxicity. Tell your doctor right away if you experience vomiting, nausea, headache, somnolence, confusion, or sleepiness. 

Buphenyl tablets are not indicated for to infants or children who weigh less than 20kg.

Do not take Buphenyl if you

  • are allergic to Buphenyl or to any of its ingredients 
  • to manage acute hyperammonemia ( sudden, severely high levels of ammonia), which is considered a medical emergency.

Buphenyl Food Interactions

Medications can interact with certain foods. In some cases, this may be harmful and your doctor will advise you to avoid certain food items. In the case of Buphenyl, there are no specific food items that you should exclude when taking this medication.

However, it is important to follow a nutritionally appropriate diet prescribed by your doctor or nutritionist. Buphenyl will be combined with dietary protein restriction and, in some cases, essential amino acid supplementation.

Other Requirements

  • Store Buphenyl at room temperature.
  • Keep this and other medications out of the reach of children and pets.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Contraindications

Buphenyl should not be used to manage acute hyperammonemia, which is a medical emergency.

PATIENT PACKAGE INSERT Buphenyl® (sodium phenylbutyrate) Tablets Buphenyl® (sodium phenylbutyrate) Powder

What is the most important information I should know about Buphenyl?

Buphenyl is prescribed along with changes in diet for long-term treatment of urea cycle disorders. Buphenyl can only be obtained with a prescription from your doctor.

Buphenyl must be taken exactly as the doctor prescribes; do not increase or decrease the dose of this medication without the doctor's approval.

What are urea cycle disorders?

Urea cycle disorders include a group of diseases, each having a specific liver enzyme deficiency. Because they are inherited, other family members may be affected. These disorders vary in severity and may be first detected at various ages, from newborn infants to adults. They lead to increased amounts of ammonia in the blood, which may cause disturbed brain function and severe brain damage. Typical signs of the disease are decreased mental awareness, vomiting, combativeness, slurred speech, unstable gait, and unconsciousness.  The diagnosis of urea cycle disorders requires special laboratory tests. These typical signs of the disease may recur after the diagnosis is made if the condition is not under control. If they do, the doctor should be notified immediately because this is a medical emergency. An infection can cause the condition to go out of control. Therefore, if a fever develops, the doctor should be seen immediately.

A patient or carrier of these disorders should wear a Medic Alert tag stating the diagnosis. In the event that the patient has a sudden, rapid accumulation of ammonia in the blood, and, therefore, in the brain, leading to unconsciousness, the doctor will be alerted to treat the disease properly.

Periodically, depending upon the severity of a particular patient's urea cycle disorder, it will be necessary to perform blood tests. These include plasma ammonia, plasma amino acid levels, and other more routine blood tests to evaluate nutritional status.

What is Buphenyl?

Buphenyl is a drug that helps to prevent ammonia from accumulating in the blood. Buphenyl aids the body in eliminating substances that produce ammonia. However, despite drug treatment, blood ammonia levels may become elevated periodically and there may be episodes of altered brain function in association with these ammonia elevations. Patients who have disease onset as newborns have a high incidence of mental retardation. Medical attention should be obtained as soon as signs appear (see above under "What are urea cycle disorders?"). Buphenyl may be used as life-long therapy or as a temporary measure until liver transplantation is performed.

What diet should I or my child follow?

In addition to taking Buphenyl, it is equally important that a prescribed diet be followed. Because there is great variability in the severity of urea cycle disorders, each patient's diet should be custom designed by a physician and a nutritionist. Because the diet is so important, it is recommended that the prescribed diet be discussed with a nutritionist who is familiar with urea cycle disorders.

Who should not take Buphenyl?

Buphenyl is prescribed only for patients with urea cycle disorders. It is not to be used for any other reason. Keep the medication in a safe place where children cannot reach it.

What other medical conditions may also be present that could increase the risk of taking Buphenyl?

Heart failure or decreased kidney function may lead to retention of the sodium content of Buphenyl with potentially serious consequences such as worsening heart failure, high blood pressure, and swelling. If these medical conditions are present, the doctor will determine if your child should take Buphenyl.

How should I or my child take Buphenyl?

The dose of Buphenyl prescribed for adults and children is based upon the patient's weight or size. It is very important that the full amount prescribed for any 24-hour period be taken. If a dose is missed it should be administered as soon as possible that same day. The total daily dose should be administered in equally divided amounts with meals.

What medications should I or my child avoid or be cautious of taking while on Buphenyl?

Patients with urea cycle disorders usually should not take Depakene® (valproic acid), a drug sometimes prescribed for seizure disorders, or Haldol® (haloperidol), a drug used to treat certain types of psychiatric or neurologic disorders. Both of these drugs have been reported to increase blood ammonia levels. Steroids may break down body protein, thereby increasing blood ammonia levels. The doctor should be consulted before administering medications containing steroids.

What medications may affect the way the body breaks down the drug?

Probenecid, a medication used to treat gout, may affect the way the kidneys excrete Buphenyl (consult the doctor for details).

What are the most common side effects of Buphenyl?

The most common side effect reported in premenopausal women taking Buphenyl was absent or irregular menstrual periods. Decreased appetite was reported in 4% of all people treated. Body odor and bad taste were each reported in 3% of all patients treated.

A breakdown product of Buphenyl has been associated mainly with sleepiness and light-headedness. Because these symptoms may also be due to the urea cycle going out of control, a doctor should see the patient immediately if these symptoms occur, so the cause can be determined.   Blood tests should be performed periodically for adverse effects and for levels of medication and its breakdown products.

How should Buphenyl be stored?

Buphenyl should be stored in a tightly closed bottle at room temperature.

This leaflet provides a brief summary of the information available on Buphenyl. The information here is incomplete and is not designed to take the place of your doctor's instructions. For more complete information, consult your physician or call or write Hyperion Therapeutics, Inc. at 601 Gateway Blvd, Suite 200, South San Francisco, CA 94080. 1-855-UCD-SUPT (1-855-823-7878)

PRINCIPAL DISPLAY PANEL - 250 Gram Bottle Carton

Buphenyl 
sodium phenylbutyrate tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:76325-496
Route of Administration ORAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SODIUM PHENYLBUTYRATE (PHENYLBUTYRIC ACID) SODIUM PHENYLBUTYRATE 500 mg
Inactive Ingredients
Ingredient Name Strength
MICROCRYSTALLINE CELLULOSE  
SILICON DIOXIDE  
MAGNESIUM STEARATE  
Product Characteristics
Color white Score no score
Shape OVAL Size 16mm
Flavor Imprint Code
Contains     
Packaging
# Item Code Package Description
1 NDC:76325-496-03 1 BOTTLE in 1 CARTON
1 250 TABLET in 1 BOTTLE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020572 05/13/1996 11/29/2016
Buphenyl 
sodium phenylbutyrate powder
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:76325-188
Route of Administration ORAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SODIUM PHENYLBUTYRATE (PHENYLBUTYRIC ACID) SODIUM PHENYLBUTYRATE 0.94 g  in 1 g
Inactive Ingredients
Ingredient Name Strength
CALCIUM STEARATE  
SILICON DIOXIDE  
Packaging
# Item Code Package Description
1 NDC:76325-188-64 1 BOTTLE in 1 CARTON
1 250 g in 1 BOTTLE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020573 04/30/1996 11/29/2016
Labeler - Hyperion Therapeutics, Inc. (807130500)
Registrant - Hyperion Therapeutics, Inc. (807130500)
Establishment
Name Address ID/FEI Operations
Pharmaceuticals International, Inc. (PII) 878265586 MANUFACTURE(76325-496, 76325-188)
Establishment
Name Address ID/FEI Operations
CU CHEMIE UETIKON GmbH 340717289 API MANUFACTURE(76325-496, 76325-188)
Revised: 09/2016   Hyperion Therapeutics, Inc.

What should i avoid while taking sodium phenylbutyrate (buphenyl)?

Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are using sodium phenylbutyrate.

For Healthcare Professionals

Applies to sodium phenylbutyrate: oral powder for reconstitution, oral tablet

General

Causality of adverse effects is sometimes difficult to determine because they may result from either the underlying disease, the patient's restricted diet, intercurrent illness, or the drug itself.[Ref]

Endocrine

Very common (10% or more): Amenorrhea/menstrual dysfunction (23%)[Ref]

Metabolic

Very common (10% or more): Acidosis (14%), hypoalbuminemia (11%)
Common (1% to 10%): Alkalosis, decreased appetite, hyperchloremia, hypophosphatemia, decreased total protein, hyperuricemia, hyperphosphatemia, hypernatremia, hypokalemia, increased weight[Ref]

Cardiovascular

Common (1% to 10%): Edema
Uncommon (0.1% to 1%): Arrhythmia[Ref]

Dermatologic

Common (1% to 10%): Rash, body odor[Ref]

Gastrointestinal

Common (1% to 10%): Abdominal pain, nausea, vomiting, constipation, dysgeusia
Uncommon (0.1% to 1%): Pancreatitis, rectal bleeding/hemorrhage, peptic ulcer, gastritis[Ref]

Hematologic

Common (1% to 10%): Anemia, leukopenia, leukocytosis, thrombocytopenia, thrombocytosis
Uncommon (0.1% to 1%): Aplastic anemia, ecchymosis[Ref]

Hepatic

Common (1% to 10%): Increased alkaline phosphatase, increased liver transaminases, hyperbilirubinemia[Ref]

Nervous system

Common (1% to 10%): Syncope, headache, bad taste/taste aversion
Frequency not reported: Somnolence, fatigue, lightheadedness, hypoacusis, disorientation, impaired memory, exacerbation of preexisting neuropathy[Ref]

Psychiatric

Common (1% to 10%): Depression, irritability[Ref]

Renal

Common (1% to 10%): Renal tubular acidosis[Ref]

Some side effects of Buphenyl may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.

(web3)